Digoxin in patients with permanent atrial fibrillation: Data from the RACE II study

Bart A. Mulder, Dirk J. Van Veldhuisen, Harry J. G. M. Crijns, Jan G. P. Tijssen, Hans L. Hillege, Marco Alings, Michiel Rienstra, Maarten P. Van den Berg, Isabelle C. Van Gelder*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1543-1550
JournalHeart Rhythm
Issue number9
Publication statusPublished - Sep 2014


  • Atrial fibrillation
  • Digoxin
  • Morbidity
  • Mortality
  • Rate control

Cite this